Anil Sukumaran - 03 May 2023 Form 4 Insider Report for INTEGRAL AD SCIENCE HOLDING CORP. (IAS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 May 2023, 17:44:11 UTC
Prior SEC filing
18 Apr 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Anil Sukumaran

Key filing fact

Anil Sukumaran filed Form 4 for INTEGRAL AD SCIENCE HOLDING CORP. (IAS) on 04 May 2023.

Key facts

  • This page summarizes Anil Sukumaran's Form 4 filing for INTEGRAL AD SCIENCE HOLDING CORP. (IAS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 04 May 2023, 17:44.

Change

  • Previous filing in this sequence was filed on 18 Apr 2023.
  • Current net transaction value: -$10,394.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IAS transaction

Common Stock, $0.001 par value

Sale

Transaction value
$10,394
Shares
-668
Change %
-0.74%
Price
$15.56
Shares after
89,820
Date
03 May 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Mandatory sale to cover tax liability associated with the vesting and settlement of restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .